Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array)
NOS; nNOS; IHPS1; NC-NOS; N-NOS; bNOS; Neuronal NOS; Constitutive NOS; NOS type I; Nitric Ocide Synthase; Peptidyl-cysteine S-nitrosylase NOS1
- Product No.CMA815Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length4h
- Detection Range0.0098-10ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.0033ng/mL.
- DownloadInstruction Manual
- UOM 48T96T
- FOB
US$ 529
US$ 756
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 83-98 | 87 |
| EDTA plasma(n=5) | 78-95 | 91 |
| heparin plasma(n=5) | 89-101 | 95 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 95-102% | 79-105% | 82-99% | 85-99% |
| EDTA plasma(n=5) | 91-104% | 95-104% | 81-102% | 80-104% |
| heparin plasma(n=5) | 83-96% | 86-93% | 90-104% | 97-105% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
Assay procedure summary
1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| PLoS One | A Novel Mechanism of Formaldehyde Neurotoxicity: Inhibition of Hydrogen Sulfide Generation by Promoting Overproduction of Nitric Oxide PubMed: 23359814 |
| J Endocrinol Invest.? | The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders Pubmed:25245337 |
| Достижения фундаментальной, клинической медицины и фармации: материалы 72-й науч. сес. сотр. ун-та, 25-26 янв | Состояние эндотелиально-сосудистого фактора у беременных с артериальной гипертензией handle:123 |
| Clinical Oral Investigations | Clinical antibacterial effectiveness and biocompatibility of gaseous ozone after incomplete caries removal Pubmed:29858659 |
| Journal of Young Pharmacists | Antioxydant and Endotheliotropic Properties 4-Hydroxy-3, 5-Di-Tret-Butyl Cinnamic Acid under Conditions of Experimental Brain Ischemia : |
| The Eurasian Journal of Medicine | Tadalafil Preserves Penile Nitric Oxide Synthase from Detrimental Effect of Paroxetine in Rats Doi: 10.5152/eurasianjmed.2018.18160 |
| Oxid Med Cell Longev | The Role of Reactive Oxygen Species and Nitric Oxide in the Inhibition of Trichophyton rubrum Growth by HaCaT Cells Pubmed: 32104540 |
| Archives of Oral Biology | Mandibular lateral deviation induces alteration in vascular endothelial growth factor expression and oxidative stress/nitric oxide generation in rat condyle, synovial … Pubmed: 31734543 |
| Dovepress | Protective Effects of Rocuronium Bromide on Ischemia-Reperfusion Injury in Skeletal Muscle Induced by Tourniquet in Patients Undergoing Elective Unilateral Total … Pubmed: 32884241 |
| Clinical Oral Investigations | Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients Pubmed:35426000 |

